Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK). (Q30414767)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK). |
scientific article |
Statements
1 reference
Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK). (English)
1 reference
Sylvia Cechova
1 reference
Jamison Chang
1 reference
Jennie Z Ma
1 reference
Qing Zeng
1 reference
Adam Gantz
1 reference
Daniel O'Connor
1 reference
Michael Lipkowitz
1 reference
Thu H Le
1 reference
5 December 2012
1 reference
1 reference
F348-55
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference